Revelation Biosciences, Inc. Unit
REVBU
REVBU was delisted on the 11th of January, 2023.
4 hedge funds and large institutions have $10.9M invested in Revelation Biosciences, Inc. Unit in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 9 closing their positions.
52% less capital invested
Capital invested by funds: $22.6M → $10.9M (-$11.7M)
64% less funds holding
Funds holding: 11 → 4 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CFN
Cordasco Financial Network
Naples,
Florida
|
+$55.6K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$54.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.78M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3.24M |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$2.53M |
| 4 |
Jane Street
New York
|
-$540K |
| 5 |
Walleye Trading
New York
|
-$523K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCL
1
Glazer Capital LLC
New York
| $10.8M | – | – | – |
|
|
CFN
2
Cordasco Financial Network
Naples,
Florida
| $52K | +$55.6K | +5,000 | New |
|
|
WAM
3
Wolverine Asset Management
Chicago,
Illinois
| $50K | +$54.6K | +4,912 | New |
|
4
UBS Group
Zurich,
Switzerland
| $13K | -$90.9K | -8,175 | -87% |
|
|
PAMP
5
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$3.78M | -350,000 | Closed |
|
|
CH
6
CVI Holdings
Wilmington,
Delaware
| – | -$3.24M | -300,000 | Closed |
|
|
SCM
7
Shaolin Capital Management
Miami,
Florida
| – | -$2.53M | -234,158 | Closed |
|
8
Walleye Capital
New York
| – | -$785 | -72,660 | Closed |
|
|
9
Jane Street
New York
| – | -$540K | -50,000 | Closed |
|
|
10
Walleye Trading
New York
| – | -$523K | -48,440 | Closed |
|
|
KIM
11
Karpus Investment Management
Pittsford,
New York
| – | -$294K | -27,200 | Closed |
|
|
EAM
12
Exos Asset Management
New York
| – | -$271K | -25,117 | Closed |
|
|
PAM
13
Panagora Asset Management
Boston,
Massachusetts
| – | -$86K | -7,931 | Closed |
|
REVBU Hedge Fund Activity: Q1 2021 in Review
4 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q1 2021, worth a combined $10.9M — down 52% from $22.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of REVBU and 2 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Cordasco Financial Network, opening a new position worth an estimated $55.6K. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $3.78M sold.
- 4 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q1 2021, down from 11 in Q4 2020.
- Funds reported $10.9M of Revelation Biosciences, Inc. Unit stock for Q1 2021, down 52% quarter-over-quarter.
- 2 funds opened new Revelation Biosciences, Inc. Unit positions in Q1 2021 and 9 closed out, a net change of -7 holders.
- The largest Revelation Biosciences, Inc. Unit buyer in Q1 2021 was Cordasco Financial Network, an estimated $55.6K added.
- The largest Revelation Biosciences, Inc. Unit seller in Q1 2021 was Polar Asset Management Partners, an estimated $3.78M sold.
Based on aggregated 13F filings for Q1 2021.